quadrivalent HPV vaccination programme for 12-year-old girls in Germany would be cost effective. Here we present the results from a … was used to compare a cervical cancer screening only strategy with a strategy of combining vaccination of females aged 12 …-17 years old and cervical cancer screening, based on the current recommendations in Germany. In addition, the impact of …

reimbursement policy for HPV vaccination compared to the suggested change. Using a homogeneous multistate Markov model, we … age for vaccination reimbursement from 13 to include ages 13 through 15 years, while also increasing coverage, results in … vaccination for women is economically justified. Consequently, we advocate for the implementation of the proposed policy …

above and below 60 years of age, respectively. We used the model to consider four scenarios: 1) vaccination of 1.5 million … persons 60 years of age or older, none below that age, 2) vaccination of 1.5 million persons below the age of 60 years, none … above that age, 3) vaccination of 900.000 persons below 60 years of age and 1.5 million person 60 years of age or older, and …

a lifetime cost-benefit analysis of investing in universal vaccination in Germany from the perspective of government … the cohorts. After taking into consideration the governmental transfers, universal HPV vaccination in Germany could result … study was to evaluate the broader economic consequences associated with HPV vaccination in males and females and to conduct …

2+ breast cancer. The aim is to assess the cost-effectiveness of adding pertuzumab to the combination of trastuzumab …

Traditional economic models of vaccination behavior simply assume that agents free-ride on the vaccination decisions of … conjectural variation model, to explain how a positive peer effect regarding vaccination behavior arises. We conduct two empirical … studies using Japanese data in these models. The first empirical analysis, using a data set on the vaccination behavior of …